|
Ashish K. Jha And Irene PapanicolasBoston Globe |
The gap between US drug prices and those abroad is not a market outcome — it is the result of deliberate political and regulatory choices.
Prior authorization has become a barrier to care rather than a safeguard against excess.
$22,000 for a $11,000 Surgery? No excuses—just market power. Cap the price.